Previous studies of MM have well-characterized miR-16-5p as both a tumor suppressor by targeting oncogenes BCL2 and CCND123–25, and as a remarkably under-expressed miRNA in MM tumor cells and tissues12,26. The gene discussed is BCL2; the disease is Miyoshi myopathy.